Medical Imaging has become an essential element in the drug discovery pipeline. HIRF offers new opportunities for national and international biotechnology companies to conduct leading clinical trials using the latest medical imaging technology within Australia's largest hospital precinct.
HIRF's position on the Herston campus situates it in close proximity to the Royal Brisbane and Women’s Hospital and partner research facilities such as The University of Queensland Centre for Clinical Research, QIMR Berghofer Medical Research Institute, and Queensland University of Technology’s Institute of Health and Biomedical Innovation.
The RBWH is one of Australia’s largest quaternary and tertiary referral teaching hospitals with capacity for more than 900 beds and access to large patient cohorts for clinical trials in dementia, oncology and other conditions. In addition, the hospital houses a large, Good Manufacturing Practice (GMP) certified, radiochemistry facility producing the latest PET radio tracers which form the basis of imaging systems used at HIRF such as PET scans.
HIRF is also closely aligned to specialised contract research organisations that have extensive experience in supporting early phase clinical trials. Notable local organisations include Q-Pharm Pty Limited, which undertakes a broad range of early phase clinical trials for clients in the global pharmaceutical and biotechnology industries; and TetraQ, which provides GLP bioanalytical services to support preclinical studies as well as early phase clinical trials and bioequivalence studies in humans.
With such expertise at its fingertips, HIRF is an excellent site for clinical imaging research in Australia.
Find out how you can get involved.